Saturday, July 19, 2008

Stock Idea: Jubilant Organosys

Karvy Stock Broking has recommended a buy rating on Jubilant Organosys with a target price of Rs 428 in its july 18, 2008 research report. "The net revenues for the quarter reported at Rs 8.27 billion exhibiting 53.1% y-o-y and 20% q-o-q growth against our estimates at Rs 7.46 billion mainly driven by strong growth witnessed from the Pharmaceutical Life Science Products & Services (PLSPS) segment. As expected, the Contract Research and Manufacturing Services (CRAMS) segment acted as the major and primary growth driver for the company contributing 54% to total net revenues and 86% to the PLSPS segment."
"The reported net profit shown de-growth of 91.1% to Rs 127.6 million in Q1FY09. As a result of higher revenue guidance of 50% vis-a-vis 35% we upgrade our earnings by 31.7 % to Rs 24.1 in FY09E & by 18.8 % to Rs 28.5 in FY10E. We revise our price target by 19 % to Rs 428 based on 15x on FY10E earnings and rate the stock as a BUY," says Karvy's research report.


The information in this publication is provided by is intended for use for Readers & Traders . Every effort is made to provide accurate information, but cannot guarantee the accuracy of the information or of the market analysis. This is a newsletter and is for informational purposes only. It is not a solicitation or offer to buy or sell futures. There is a high risk of loss in trading futures. You should not trade with money that you cannot afford to lose. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this newsletter. The past performance of any trading system or methodology is not necessarily indicative of future results.

free counter